CovalX
|
Year Established:
2005 |
|
|
Website:
covalx.com |
|
|
Headquarters:
Zurich, CH |
|
|
Company Type:
Small Business (1-10M TTM Revenue) |
CovalX offers a complete solution for the full characterization of biotherapeutics. Our company is a leader in protein interaction analysis by mass spectrometry taking benefits of its unit technology platform (Epitope mapping HDX-MS and XL-MS; aggregation analysis, protein complex stoechiometry, cmpds/target interactions, SPR affinity analysis) . CovalX is offering all the analytical services for the characterization of your biotherapeutics: Denovo sequencing, LC-MS, MALDI-MS, Glycans characterization and the complementary analysis for the preparation of IND subimission following ICH-Q6B guidlines.
| Site | Badges | |
|---|---|---|
| CovalX Analytics SAS Technopole Montesquieu MARTILLAC, , 33650 France | ||
| CovalX AG Headquarters Schützengasse 23 Zurich, , 8001 Switzerland | ||
| CovalX AG Schützengasse 23 Zurich, , 8001 Switzerland | ||
| CovalX Analytics Inc 12 Gill Street Woburn, MA, 01801 United States | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.